Location History:
- Souffelweyersheim, FR (2016)
- Strasbourg, FR (2022)
Company Filing History:
Years Active: 2016-2025
Title: Rachid Baati: Innovator in Pharmaceutical Chemistry
Introduction
Rachid Baati is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of three patents to his name, Baati's work focuses on developing compounds that have therapeutic applications.
Latest Patents
One of Baati's latest patents involves 3,6-disubstituted-2-pyridinaldoxime scaffolds. This invention relates to a compound of formula (I), or one of its pharmaceutically acceptable salts, where R1, R2, and —X—Y— have specific definitions. The patent also discusses the use of such a compound in therapy and outlines a process for preparing it. Another significant patent includes 6-Substituted 3-Fluoro-2-Pyridinaldoxime, which details a compound of formula (II) and a process for preparing these compounds through a chemoselective Sonogashira reaction. This patent also covers a pharmaceutical composition that includes at least one compound of formula (II) and at least one pharmaceutically acceptable support. Furthermore, it highlights the use of such compounds in treating nervous and respiratory failures due to organophosphorous nerve agent intoxication, neurological diseases like Alzheimer's, cancer, and as antiviral drugs.
Career Highlights
Rachid Baati has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the University of Strasbourg. His research and innovations have contributed to advancements in therapeutic compounds, showcasing his expertise in the field.
Collaborations
Baati has collaborated with notable colleagues, including José Dias and Jagadeesh Yerri. These partnerships have likely enhanced his research and development efforts in pharmaceutical chemistry.
Conclusion
Rachid Baati is a prominent inventor whose work in pharmaceutical chemistry has led to the development of innovative compounds with significant therapeutic potential. His contributions continue to impact the field positively.